Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors
Systemic administration of etoposide is effective in treating metastatic, recurrent or refractory brain tumors, but penetration into the cerebrospinal fluid is extremely poor. This study was designed to determine the safety and toxicity profile of intraventricular etoposide administration and was af...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
4 May 2016
|
| In: |
Journal of neuro-oncology
Year: 2016, Jahrgang: 128, Heft: 3, Pages: 463-471 |
| ISSN: | 1573-7373 |
| DOI: | 10.1007/s11060-016-2133-x |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s11060-016-2133-x Verlag, Volltext: https://doi.org/10.1007/s11060-016-2133-x 
|
| Verfasserangaben: | Kristian W. Pajtler, Stephan Tippelt, Nele Siegler, Stefanie Reichling, Martina Zimmermann, Ruth Mikasch, Udo Bode, Astrid Gnekow, Torsten Pietsch, Martin Benesch, Stefan Rutkowski, Gudrun Fleischhack |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1583890912 | ||
| 003 | DE-627 | ||
| 005 | 20230427161322.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181120s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11060-016-2133-x |2 doi | |
| 035 | |a (DE-627)1583890912 | ||
| 035 | |a (DE-576)513890912 | ||
| 035 | |a (DE-599)BSZ513890912 | ||
| 035 | |a (OCoLC)1341023941 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pajtler, Kristian Wilfried |d 1980- |e VerfasserIn |0 (DE-588)1012877264 |0 (DE-627)662768558 |0 (DE-576)346086256 |4 aut | |
| 245 | 1 | 0 | |a Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors |c Kristian W. Pajtler, Stephan Tippelt, Nele Siegler, Stefanie Reichling, Martina Zimmermann, Ruth Mikasch, Udo Bode, Astrid Gnekow, Torsten Pietsch, Martin Benesch, Stefan Rutkowski, Gudrun Fleischhack |
| 264 | 1 | |c 4 May 2016 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 20.11.2018 | ||
| 520 | |a Systemic administration of etoposide is effective in treating metastatic, recurrent or refractory brain tumors, but penetration into the cerebrospinal fluid is extremely poor. This study was designed to determine the safety and toxicity profile of intraventricular etoposide administration and was affiliated with the prospective, multicenter, nonblinded, nonrandomized, multi-armed HIT-REZ-97 trial. The study enrolled 68 patients, aged 1.1-34.6 (median age 11 years). Adverse events that could possibly be related to intraventricular etoposide therapy were documented and analyzed. Intraventricular etoposide was simultaneously administered with either oral or intravenous chemotherapy in 426 courses according to three major schedules varying in dosing (0.25-1 mg), frequency of administration (bolus injection, every 12 or 24 h), course duration (5-10 days) and length of interval between courses (2-5 weeks). Potential treatment-related adverse effects included transient headache, seizures, infection of the reservoir, nausea and neuropsychological symptoms. Hematological side effects were not observed. One patient, with history of multiple prior therapies, who received long-term intraventricular and oral etoposide treatment developed acute myeloid leukemia as a secondary malignancy. Overall intraventricular etoposide is well tolerated. The results of this study have warranted a phase II trial to determine the effectiveness of this regimen in disease stages with very limited therapeutic options. | ||
| 650 | 4 | |a ATRT | |
| 650 | 4 | |a Ependymoma | |
| 650 | 4 | |a Medulloblastoma | |
| 650 | 4 | |a Pediatric brain tumors | |
| 650 | 4 | |a Progression | |
| 650 | 4 | |a Relapse | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neuro-oncology |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1983 |g 128(2016), 3, Seite 463-471 |h Online-Ressource |w (DE-627)32046122X |w (DE-600)2007293-4 |w (DE-576)107058944 |x 1573-7373 |7 nnas |a Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors |
| 773 | 1 | 8 | |g volume:128 |g year:2016 |g number:3 |g pages:463-471 |g extent:9 |a Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11060-016-2133-x |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s11060-016-2133-x |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181120 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1012877264 |a Pajtler, Kristian Wilfried |m 1012877264:Pajtler, Kristian Wilfried |d 910000 |d 910500 |e 910000PP1012877264 |e 910500PP1012877264 |k 0/910000/ |k 1/910000/910500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1583890912 |e 303280423X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors","title_sort":"Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"4 May 2016","dateIssuedKey":"2016"}],"recId":"1583890912","id":{"doi":["10.1007/s11060-016-2133-x"],"eki":["1583890912"]},"physDesc":[{"extent":"9 S."}],"note":["Gesehen am 20.11.2018"],"relHost":[{"recId":"32046122X","origin":[{"dateIssuedKey":"1983","publisher":"Springer Science + Business Media B.V ; Kluwer","dateIssuedDisp":"1983-","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumorsJournal of neuro-oncology","id":{"eki":["32046122X"],"issn":["1573-7373"],"zdb":["2007293-4"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 11.06.2018","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1983 -"],"title":[{"title":"Journal of neuro-oncology","title_sort":"Journal of neuro-oncology"}],"part":{"issue":"3","pages":"463-471","extent":"9","year":"2016","text":"128(2016), 3, Seite 463-471","volume":"128"},"language":["eng"]}],"name":{"displayForm":["Kristian W. Pajtler, Stephan Tippelt, Nele Siegler, Stefanie Reichling, Martina Zimmermann, Ruth Mikasch, Udo Bode, Astrid Gnekow, Torsten Pietsch, Martin Benesch, Stefan Rutkowski, Gudrun Fleischhack"]},"person":[{"family":"Pajtler","role":"aut","given":"Kristian Wilfried","display":"Pajtler, Kristian Wilfried"}]} | ||
| SRT | |a PAJTLERKRIINTRAVENTR4201 | ||